Literature DB >> 1603504

The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.

R Gonen1, R Perez, M David, H Dar, R Merksamer, M Sharf.   

Abstract

OBJECTIVE: We conducted this cohort analytic study to determine whether women with unexplained elevations of maternal serum hCG at 16-20 weeks' gestation are at increased risk for pregnancy complications and adverse perinatal outcomes.
METHODS: The inclusion criteria were a singleton gestation, a confirmed gestational age, and an hCG level greater than 2.5 multiples of the median (MOM). The exclusion criteria were fetal anomalies, an abnormal karyotype, and a maternal serum alpha-fetoprotein (MSAFP) level greater than 2.5 MOM. A group of randomly selected women with normal hCG and MSAFP levels served as controls.
RESULTS: Of the 6011 women screened, 284 (4.7%) had an unexplained elevated hCG level. Patients with elevated levels of hCG had a significantly higher risk for hypertension (odds ratio 4.4; 95% confidence interval [CI] 1.9-10) and fetal growth restriction (odds ratio 2.8; 95% CI 1-7). Women with hCG levels greater than 4 MOM also had an increased risk of preterm delivery (odds ratio 3.3; 95% CI 1.3-8.2).
CONCLUSION: Pregnancies with unexplained elevated hCG levels should be regarded as high-risk pregnancies and managed accordingly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1603504

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes.

Authors:  Hümeyra Öztürk; Salim Erkaya; Sibel Altınbaş; Burak Karadağ; Nazan Vanlı Tonyalı; Demet Özkan
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15

2.  Prenatal diagnosis and fetal therapy--what lies in future?

Authors:  J Mauldin
Journal:  Indian J Pediatr       Date:  2000-12       Impact factor: 1.967

Review 3.  Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.

Authors:  Rachel K Morris; Jeltsje S Cnossen; Marloes Langejans; Stephen C Robson; Jos Kleijnen; Gerben Ter Riet; Ben W Mol; Joris A M van der Post; Khalid S Khan
Journal:  BMC Pregnancy Childbirth       Date:  2008-08-04       Impact factor: 3.007

4.  Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome.

Authors:  Georgios Androutsopoulos; Panagiotis Gkogkos; Georgios Decavalas
Journal:  Int J Endocrinol Metab       Date:  2013-04-01

5.  Placental trophoblast syncytialization potentiates macropinocytosis via mTOR signaling to adapt to reduced amino acid supply.

Authors:  Xuan Shao; Guangming Cao; Dunjin Chen; Juan Liu; Bolan Yu; Ming Liu; Yu-Xia Li; Bin Cao; Yoel Sadovsky; Yan-Ling Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779

6.  Human chorionic gonadotropin (hCG) concentrations during the late first trimester are associated with fetal growth in a fetal sex-specific manner.

Authors:  Mirjana Barjaktarovic; Tim I M Korevaar; Vincent W V Jaddoe; Yolanda B de Rijke; Theo J Visser; Robin P Peeters; Eric A P Steegers
Journal:  Eur J Epidemiol       Date:  2016-10-05       Impact factor: 8.082

7.  The Effect of Serum β-Human Chorionic Gonadotropin on Pregnancy Complications and Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis.

Authors:  Ju Huang; Yuying Liu; Hua Yang; Yuanfang Xu; Wei Lv
Journal:  Comput Math Methods Med       Date:  2022-09-09       Impact factor: 2.809

8.  The role of maternal serumbeta-HCG and PAPP-A levels at gestational weeks 10 to 14 in the prediction of pre-eclampsia.

Authors:  Ozkan Ozdamar; Ismet Gun; Ugur Keskin; Necmettin Kocak; Ercument Mungen
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.